Patents Assigned to MEDODERM GMBH
  • Patent number: 11975120
    Abstract: A chitosan for use in an antimicrobial treatment of a patient's tissue and a pharmaceutical composition comprising a chitosan for use in an antimicrobial treatment of a patient's tissue. A method of treating a microbial infection, the method comprising the step of administering to a patient an effective amount of a chitosan and an aqueous solution comprising chitosan. A chitosan or a pharmaceutical composition comprising a chitosan for use in an epithelial cell growth stimulating treatment of a patient's tissue. A method of stimulating the growth of epithelial cells the method comprising the step of administering to a patient or to an epithelial cells containing cell culture an effective amount of a chitosan or a pharmaceutical composition comprising chitosan. A tissue dressing material characterized in that it consists of chitosan or a chitosan comprising composition.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: May 7, 2024
    Assignee: Medoderm Gmbh
    Inventors: Rivelino Montenegro, Thomas Freier, Karsten Henco
  • Publication number: 20230381217
    Abstract: Liquid compositions are used to differentially promote the growth of the microbiome. The liquid composition forms a membrane when applied to the skin of a subject. The liquid composition as well as the membrane comprise chitosan or a salt thereof with a degree of acetylation of 20% or less and at least one additional agent. Also disclosed are pharmaceutical compositions for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease.
    Type: Application
    Filed: October 14, 2021
    Publication date: November 30, 2023
    Applicant: Medoderm GMBH
    Inventors: Günter Bauer, Manfred Beleut, Karsten Henco
  • Patent number: 11311644
    Abstract: A chitosan for use in an antimicrobial treatment of a patient's tissue and a pharmaceutical composition comprising a chitosan for use in an antimicrobial treatment of a patient's tissue. A method of treating a microbial infection, the method comprising the step of administering to a patient an effective amount of a chitosan and an aqueous solution comprising chitosan. A chitosan or a pharmaceutical composition comprising a chitosan for use in an epithelial cell growth stimulating treatment of a patient's tissue. A method of stimulating the growth of epithelial cells the method comprising the step of administering to a patient or to an epithelial cells containing cell culture an effective amount of a chitosan or a pharmaceutical composition comprising chitosan. A tissue dressing material characterized in that it consists of chitosan or a chitosan comprising composition.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 26, 2022
    Assignee: Medoderm GmbH
    Inventors: Rivelino Montenegro, Thomas Freier, Karsten Henco
  • Publication number: 20190321511
    Abstract: A chitosan for use in an antimicrobial treatment of a patient's tissue and a pharmaceutical composition comprising a chitosan for use in an antimicrobial treatment of a patient's tissue. A method of treating a microbial infection, the method comprising the step of administering to a patient an effective amount of a chitosan and an aqueous solution comprising chitosan. A chitosan or a pharmaceutical composition comprising a chitosan for use in an epithelial cell growth stimulating treatment of a patient's tissue. A method of stimulating the growth of epithelial cells the method comprising the step of administering to a patient or to an epithelial cells containing cell culture an effective amount of a chitosan or a pharmaceutical composition comprising chitosan. A tissue dressing material characterized in that it consists of chitosan or a chitosan comprising composition.
    Type: Application
    Filed: July 1, 2019
    Publication date: October 24, 2019
    Applicant: MEDODERM GMBH
    Inventors: Rivelino Montenegro, Thomas Freier, Karsten Henco
  • Patent number: 10207022
    Abstract: A tissue dressing material for being applied in contact with a tissue of a patient. The tissue dressing material's main component is deacetylated native chitosan. Moreover, a liquid tissue dressing material for being applied in contact with a tissue of a patient, the tissue dressing material being an aqueous mixture. The main component of the constituent(s) of the mixture other than water is deacetylated native chitosan.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: February 19, 2019
    Assignee: MEDODERM GMBH
    Inventors: Rivelino Montenegro, Thomas Freier
  • Patent number: 9439998
    Abstract: The present invention relates to methods for disinfecting or decontaminating a material or for preventing an infection or contamination of a material. The invention further relates to compositions which are suitable for disinfecting a material or for preventing an infection or contamination of a material and to uses of such compositions. The invention further relates to a medical use of chitosan and to a pharmaceutical composition comprising the chitosan. The invention further relates to a method of treating a microbial infection and to an aqueous solution comprising chitosan. The invention moreover relates to a chitosan or a pharmaceutical composition comprising a chitosan for an epithelial cell growth stimulating treatment of a patient's tissue and to a method of stimulating the growth of epithelial cells. The invention also relates to a tissue dressing material.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: September 13, 2016
    Assignee: Medoderm GmbH
    Inventors: Karsten Henco, Thomas Freier, Rivelino Montenegro
  • Publication number: 20120252755
    Abstract: The present invention relates to methods for disinfecting or decontaminating a material or for preventing an infection or contamination of a material. The invention further relates to compositions which are suitable for disinfecting a material or for preventing an infection or contamination of a material and to uses of such compositions. The invention further relates to a medical use of chitosan and to a pharmaceutical composition comprising the chitosan. The invention further relates to a method of treating a microbial infection and to an aqueous solution comprising chitosan. The invention moreover relates to a chitosan or a pharmaceutical composition comprising a chitosan for an epithelial cell growth stimulating treatment of a patient's tissue and to a method of stimulating the growth of epithelial cells. The invention also relates to a tissue dressing material.
    Type: Application
    Filed: September 1, 2010
    Publication date: October 4, 2012
    Applicant: MEDODERM GMBH
    Inventors: Karsten Henco, Thomas Freier, Rivelino Montenegro